Previous 10 | Next 10 |
2023-08-14 16:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-03 11:58:02 ET Teleflex, Inc. (TFX) Q2 2023 Earnings Conference Call August 03, 2023, 08:00 ET Company Participants Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas Powell - EVP & CFO Conferen...
2023-08-03 06:45:32 ET Teleflex press release ( NYSE: TFX ): Q2 Non-GAAP EPS of $3.41 beats by $0.20 . Revenue of $743.3M (+5.5% Y/Y) beats by $13.41M . 2023 guidance summary Raising GAAP revenue growth guidance to 5.80% to 6.55% Raising the low end of ...
WAYNE, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended July 2, 2023. Second quarter financial summary Revenues of $743.3 million, up 5.5% com...
2023-08-02 15:03:50 ET Teleflex ( NYSE: TFX ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open. The consensus EPS Estimate is $3.21 (-5.3% Y/Y) and the consensus Revenue Estimate is $729.89M (+3.6% Y/Y). Over the last 2 years, TF...
WAYNE, Pa., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ ™ Hemostatic Device to include mild and moderate bleeding in ...
2023-07-27 15:05:43 ET Summary Teleflex Incorporated saw a tougher 2022, but has found some operating momentum again. The company is using this momentum to announce its next bolt-on deal, being strategic but a bit expensive. Following a 20% re-rating over the past year, I thin...
2023-07-26 07:24:49 ET Teleflex Incorporated ( NYSE: TFX ) fell ~5% pre-market Wednesday after announcing a deal to acquire privately held Palette Life Sciences AB, a medical device maker focused on prostate cancer therapy. Per the terms, Teleflex ( TFX ), based in Wayne...
Acquisition will accelerate global commercial expansion of the company’s product portfolio, including Barrigel® SANTA BARBARA, Calif. and STOCKHOLM, Sweden, July 26, 2023 (GLOBE NEWSWIRE) -- Palette Life Sciences , a fully-integrated global life sciences company dedicated to...
WAYNE, Pa., July 26, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire privately-held Palette Life Sciences AB for an upfront cash payment of $600 million...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024. To participate in the conference call, ple...
2024-07-09 10:00:05 ET Richard Newitter from Truist Financial issued a price target of $235.00 for TFX on 2024-07-09 08:48:00. The adjusted price target was set to $235.00. At the time of the announcement, TFX was trading at $211.73. The overall price target consensus is...